Key Takeaways
- Major automotive manufacturers General Motors (GM) and Toyota Motor North America reported significant sales increases in Q3 and September, respectively, with electric vehicle (EV) deliveries showing particularly strong growth.
- European stock markets closed notably higher, with healthcare stocks experiencing their largest daily surge since 2008 following a U.S. deal with Pfizer (PFE) to lower drug prices.
- U.S. stock markets rebounded with slight gains despite ongoing government shutdown concerns, while the Atlanta Fed's GDPNow forecast for Q3 was slightly revised down to 3.8%.
- Barclays downgraded AT&T (T) to Equal Weight, and Fermi (FRMI) shares saw a strong market debut after its IPO.
- Venezuela's oil exports reached over 1 million barrels per day in September, marking the first time since early 2020.
Automotive Sector Drives Strong Sales with EV Momentum
The automotive industry demonstrated robust performance in September and the third quarter of 2025, particularly in the electric vehicle segment. General Motors (GM) reported a substantial 7.7% increase in its U.S. vehicle deliveries for Q3, totaling 710,347 units. This growth was significantly bolstered by a 107% surge in electric vehicle deliveries, reaching 66,501 units.
Similarly, Toyota Motor North America announced sales of 185,748 vehicles in September, with 85,092 of those being electric vehicles. Subaru of America also contributed to the positive trend, selling 46,007 vehicles in September 2025. These figures highlight a continued strong consumer appetite for new vehicles, with a clear acceleration in the adoption of EVs.
European Markets Rally, U.S. Stocks See Modest Gains
European stock markets experienced a strong trading day, with major indices closing significantly higher. Britain's FTSE 100 rose by 1.12%, Germany's DAX was up 1.13%, France's CAC 40 gained 1.07%, and Spain's IBEX increased by 0.54%. A standout performer was the European healthcare sector, which saw an impressive 5.2% increase, marking its biggest daily rise since 2008. This surge was attributed to reduced uncertainty following a U.S. deal with Pfizer (PFE) to lower prescription drug prices in the Medicaid program.
In the United States, stock markets rebounded with slight gains. The S&P 500 rose by 0.1%, the NASDAQ also climbed 0.1%, and the Dow increased by 0.2%. These modest gains occurred despite concerns surrounding a potential U.S. government shutdown, which impacted market sentiment earlier in the day.
Economic Indicators and Corporate Actions
The Atlanta Federal Reserve's GDPNow model provided an updated forecast for Q3 GDP, revising it slightly downwards to 3.8% from a previous estimate of 3.9%. This adjustment reflects ongoing economic data inputs.
In corporate news, Barclays adjusted its rating for AT&T Inc. (T), reducing it from Overweight to Equal Weight. Meanwhile, Fermi (FRMI) shares made a notable debut on the market, opening strongly at $27.49 after its Initial Public Offering (IPO) was priced at $21.
On the commodities front, Venezuela's oil exports reached a significant milestone in September, surpassing 1 million barrels per day for the first time since early 2020. This increase highlights a notable recovery in the nation's oil output and sales.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.